{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:36:56Z","timestamp":1789807016896,"version":"4.0.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/rhu.0b013e318262df28","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T18:25:30Z","timestamp":1355941530000},"page":"261-262","source":"Crossref","is-referenced-by-count":5,"title":["A Rare Case of Mixed Connective Tissue Disease Complicated With Neuromyelitis Optica"],"prefix":"10.1097","volume":"18","author":[{"given":"Konstantinos","family":"Parperis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210207","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","article-title":". Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.","volume":"42","author":"Burdt","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R2-11-20210207","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02208024","article-title":". Neurological features in overlap syndrome.","volume":"10","author":"Nitsche","year":"1991","journal-title":"Clin Rheumatol"},{"key":"R3-11-20210207","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0733-8619(03)00057-4","article-title":"Neurologic manifestations of connective tissue disease.","volume":"20","author":"Nadeau","year":"2002","journal-title":"Neurol Clin"},{"key":"R4-11-20210207","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0022-510X(94)90264-X","article-title":"Mixed connective tissue disease: recurrent episodes of optic neuropathy and transverse myelopathy. Successful treatment with plasmapheresis.","volume":"126","author":"Flechtner","year":"1994","journal-title":"J Neurol Sci"},{"key":"R5-11-20210207","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":". A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"R6-11-20210207","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":". IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"R7-11-20210207","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":". Neuromyelitis optica and non organ-specific autoimmunity.","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"R8-11-20210207","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":". Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult Scler"},{"key":"R9-11-20210207","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":". Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"R10-11-20210207","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":". A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"R11-11-20210207","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devics neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine.","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"R12-11-20210207","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":". Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e318262df28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:57:16Z","timestamp":1620971836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201208000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e318262df28","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}